Renaissance Technologies
TMCI icon

Renaissance Technologies’s Treace Medical Concepts TMCI Stock Holding History

Renaissance Technologies’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192K Sell
48,300
-474,600
-91% -$1.3M ﹤0.01% 2889
2026
Q1 		$701K Buy
+522,900
New +$1.04M ﹤0.01% 2442
2025
Q2 		– Sell
-126,800
Closed -$1.06M – 3901
2025
Q1 		$1.06M Buy
126,800
+14,800
+13% +$133K ﹤0.01% 2385
2024
Q4 		$833K Buy
112,000
+76,700
+217% +$513K ﹤0.01% 2595
2024
Q3 		$205K Sell
35,300
-171,200
-83% -$1.1M ﹤0.01% 3120
2024
Q2 		$1.37M Buy
206,500
+29,100
+16% +$235K ﹤0.01% 2125
2024
Q1 		$2.31M Buy
177,400
+139,098
+363% +$1.85M ﹤0.01% 1935
2023
Q4 		$488K Sell
38,302
-195,698
-84% -$1.98M ﹤0.01% 2794
2023
Q3 		$3.07M Buy
+234,000
New +$4.28M 0.01% 1599
2023
Q2 		– Sell
-75,600
Closed -$1.9M – 4261
2023
Q1 		$1.9M Buy
75,600
+37,900
+101% +$890K ﹤0.01% 2058
2022
Q4 		$867K Sell
37,700
-30,900
-45% -$711K ﹤0.01% 2613
2022
Q3 		$1.51M Buy
+68,600
New +$1.33M ﹤0.01% 2229

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies's TMCI Position: Q2 2026 in Review

Renaissance Technologies reduced its Treace Medical Concepts (TMCI) stake by 91% in Q2 2026, selling an estimated $1.3M and leaving 48,300 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #2889.

Renaissance Technologies first reported a position in TMCI in Q3 2022 and has held it in 12 quarters since. The position peaked at $3.07M in Q3 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Renaissance Technologies held 48,300 shares of Treace Medical Concepts worth $192K as of Q2 2026.
  • Renaissance Technologies sold 474,600 Treace Medical Concepts shares in Q2 2026, an estimated $1.3M.
  • Treace Medical Concepts made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2889 holding.
  • Renaissance Technologies first reported a position in Treace Medical Concepts in Q3 2022 and has held it in 12 quarters since.
  • Renaissance Technologies's Treace Medical Concepts position peaked at $3.07M in Q3 2023.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.